Ignite Creation Date:
2024-05-06 @ 3:45 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04740437
Status:
UNKNOWN
Last Update Posted:
2021-02-05
First Post:
2021-02-02
Brief Title:
Systematic IPP VS Symptomatic IPP in GERD Prevention After POEM for Achalasia A Comparative Retrospective Analysis
Sponsor:
University Hospital Montpellier
Organization:
University Hospital Montpellier
Study Overview
Official Title:
Interest of Systematic PPI Therapy After POEM vs Symptomatic Use of PPI Therapy in Prevention of Gastroesophageal Reflux Disease After POEM for Esophageal Achalasia A Comparative Retrospective Analysis
Status:
UNKNOWN
Status Verified Date:
2021-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IPPOEM-Retro
Brief Summary:
POEM is a minimally invasive endoscopic therapy that is highly efficacy in the treatment of achalasia of any type POEM has an increased risk of GERD Systematic PPI therapy has never been studied for the prevention of post-POEM GERD
The investigators wish to retrospectively compare patients who have received routine PPI therapy vs patients who dont
The investigators wish to retrospectively compare patients who have received routine PPI therapy vs patients who dont
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None